Related Experiment Video
Updated: Jun 27, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
[Aspergillosis]
Tsunehiro Ando1, Atsuko Moriya, Kazutoshi Shibuya
1Department of Infectious Diseases, Japanese Red Cross Medical Center.
Abstract:
Aspergillosis occurs as an opportunistic infection, and is known as the disease whose diagnosis and treatment are particularly difficult. Japan's first guidelines for the diagnosis and management of invasive fungal infection were revised in 2007, and it is expected that the guidelines may encourage the standardization of the management of fungal infection. The algorithm of the guidelines is composed of three categories of diagnosis: "Proven infection", "Clinically documented infection or Probable infection" and "Possible infection"; and 2 categories of therapy: "empiric", and "targeting" therapy. The early diagnosis and establishment of treatment methods for, pulmonary aspergillosis, neither of which are adequate presently, are a pressing need. However, the recent development of several serological diagnostic methods and launching new antifungal drugs changes the diagnosis and therapeutic strategy for pulmonary aspergillosis.
Insights
Aspergillosis diagnosis and treatment are challenging. Revised guidelines aim to standardize care for invasive fungal infections, including pulmonary aspergillosis, with new diagnostic methods and antifungal drugs improving strategies.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Clinical Guidelines
Context:
- Aspergillosis is an opportunistic infection with difficult diagnosis and treatment.
- Japan's 2007 guidelines for invasive fungal infection aimed to standardize management.
- Pulmonary aspergillosis diagnosis and treatment require urgent improvement.
Purpose:
- To outline the diagnostic and therapeutic algorithm from Japan's revised guidelines for invasive fungal infections.
- To highlight the challenges in diagnosing and treating pulmonary aspergillosis.
- To discuss the impact of new diagnostic methods and antifungal drugs on aspergillosis management.
Summary:
- The guidelines categorize infections into 'Proven', 'Clinically documented/Probable', and 'Possible'.
- Therapy is divided into 'empiric' and 'targeting' approaches.
- Recent advancements in serological diagnostics and new antifungal agents are transforming treatment strategies for pulmonary aspergillosis.
Impact:
- Standardization of invasive fungal infection management in Japan.
- Potential for improved early diagnosis and treatment outcomes for aspergillosis.
- Adaptation of clinical practice due to evolving diagnostic and therapeutic options.
Related Concept Videos
Fungal Phylum Ascomycota
Amebiasis
Toxoplasmosis
American Trypanosomiasis
Atypical Pneumonia
Rocky Mountain Spotted Fever
